Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Yakkang Biotech: Yakang Biotech Report for the Third Quarter of 2024
Oct 30 12:00 ET
Yakkang Biotech Report for the Third Quarter of 2024
Yakkang Biotech 2024 Semi-Annual Report
Aug 28 12:00 ET
Summary of Yakkang Biotech\'s 2024 Semi-Annual Report
Read more
Updated: Dec 3, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data